Urinary Catheters Market - Growth, Trends, and Forecasts (2023 - 2028)

The urinary catheters market is expected to register a CAGR of nearly 5.5% during the forecast period of 2022-2027.

A profound impact on the urinary catheter market is expected due to the COVID-19 scenario. As the number of cases is still on the rise, the demand for urinary catheters is also expected to increase since urinary catheters are used in some critically ill patients suffering from COVID-19. Thus, this is expected to impact the demand for urinary catheters positively.

The primary factors driving the growth of the urinary catheter market include the rising prevalence of urinary incontinence, the growing geriatric population, and technological advancement in the material used for catheters.

Increasing funding provides support for more innovative product launches in the market. For instance, in December 2020, Ingenion Medical Ltd received about GBP 100,000 funding from the Innovative UK to develop its product CymActive urinary catheter. It is a novel medical device that is designed for treating male patients suffering from urinary retention. Urinary incontinence is an underdiagnosed and underreported condition that is likely to increase with age and majorly affects the elderly population. Furthermore, as per the World Ageing Population report, in 2019, about 702.9 million people living were aged 65 years and above, and this number is expected to reach 1,548.9 million by 2050. Thus, this is expected to fuel the market growth.

Urinary Catheters Market Trends

Benign Prostate Hyperplasia (BPH) is Expected to Show a Significant Growth in the Urinary Catheter Market During the Forecast Period

Benign prostate hyperplasia (BPH) is expected to show significant growth in the urinary catheter market during the forecast period. However, with the COVID-19 outbreak, a delay in diagnosis and treatment was observed in the case of BPH. This overall impacted negatively on the market studied in this segment. As per the study 'Gravas S, Fournier G, Oya M, et al. Prioritising urological surgery in the COVID-19 era: a global reflection on guidelines', published in June 2020, about 2,494 urologists were surveyed from 76 countries wherein BPH was preferred as one of the lowest priorities in terms of treatment in non-oncological procedures.

BPH is a very common condition among older men. A study titled, 'The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males', published in May 2020, revealed that with increasing aging, the prevalence of BPH also increased among the Chinese population. BPH is often associated with the conditions such as urinary incontinence, frequent urination, and urine initiation difficulties. Thus, the growing burden of BPH is further expected to impact the overall burden of urinary incontinence, thereby flourishing the market growth in this segment.

North America Accounted for the Largest Share in the Market

North America occupied a major share in the urinary catheter market, and the region is expected to show a similar trend over the forecast period. A profound impact is expected on the market due to the COVID-19 outbreak. In February 2021, Health Canada approved the TempSensor catheter designed by Bactguard. As urinary catheters are being used in some cases of critically ill COVID-19 patients, the introduction of such products can positively impact the market studied.

The growing burden of urinary incontinence and the rising geriatric population are some of the driving factors in this region for the market studied. According to the Urology Care Foundation, 2019 revision, one-third of men and women in the United States suffer from urinary incontinence. About 33 million have overactive bladders, representing symptoms of urgency, frequency, and with or without urge incontinence.

Furthermore, with the introduction of technologically advanced products, the market in this region is expected to fuel over the forecast period. For instance, in February 2019, Safe Medical Design Inc. received approval from the United States Food & Drug Administration (US FDA) for its product Signal Catheter. Thus, the factors mentioned above are expected to impact the market growth positively.

Urinary Catheters Market Competitor Analysis

The urinary catheter market is moderately fragmented, with the presence of a few major players and small players. The market players are focusing on R&D to develop technologically advanced products in the market. The barriers for the new entrants are high in this industry, and hence, few major market players hold the maximum market share. Some of the major players in the market are B Braun Melsungen AG, Boston Scientific Corporation, Teleflex Inc., and Medtronic PLC, among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support